IRCCS Ospedale Galeazzi- Sant’Ambrogio provides specialized Schizophrenia Disorder Treatment with an emphasis on accurate psychiatric evaluation, personalized medication management, and comprehensive long-term support. Established in 1963, the SSN accredited hospital is based in milan, Italy and has 560 beds supported by modern psychiatric and rehabilitation facilities.

Schizophrenia Disorder Treatment is planned after evaluating psychotic symptoms, cognitive difficulties, functional challenges, medical history, and previous treatment response. Antipsychotic medication is usually central to treatment, while psychotherapy and psychosocial interventions can support communication, daily living, and social functioning. In selected cases, long-acting injectable antipsychotics may help with medication adherence. Regular follow-up allows the care team to monitor symptom control, treatment effects, physical health, and the need for adjustments.